August 2025
1. LUO H, Liao G, Liu Y
   Efficacy of Neoadjuvant Hormone Therapy Combined with Radical Prostatectomy in Improving Oncological Outcomes for Patients with cT3 Prostate Cancer: A Systematic Review and Meta-Analysis.
   Urol Int. 2025 Aug 13:1-37. doi: 10.1159/000547875.
   

   >> Share

   
   July 2025
2. PHILIPPOU C, Gloger S, Ubrig B, Bitterlich N, et al
   Estimating Bone Metastasis Risk in Prostate Cancer: A Three-Parameter Model using BSP, ISUP Grading, and Tumor Progression.
   Urol Int. 2025 Jul 25:1-34. doi: 10.1159/000547556.
   

   >> Share

   
   June 2025
3. PINA-VAZ T, Costa Silva A, Costa G, Goncalves M, et al
   Sexually Transmitted Infections in Prostate Cancer: A Prospective Multicenter Analysis.
   Urol Int. 2025 Jun 21:1-13. doi: 10.1159/000545208.
   

   >> Share

   
   May 2025
4. NIRAZUKA A, Nakayama A, Inoue M, Tsujioka H, et al
   Impact of an Early Prostate-Specific Antigen Response on Biochemical Progression During Upfront Androgen Receptor Signal Inhibitor Therapy for Metastatic Hormone-Sensitive Prostate Cancer.
   Urol Int. 2025 May 22:1-18. doi: 10.1159/000546327.
   

   >> Share

   
   April 2025
5. BORKOWETZ A, Wullich B, Saar M, Schmidt-Hegemann N, et al
   Treatment strategies in oligo-metastatic prostate cancer - a nation-wide survey.
   Urol Int. 2025 Apr 14:1-20. doi: 10.1159/000545630.
   

   >> Share

   
   January 2025
6. FIORELLO N, Zucchi A, Gregori F, Romei G, et al
   Urinary Leakage after Robot-Assisted Radical Prostatectomy: Is Always Predictive of Functional Results?
   Urol Int. 2025;109:68-73.
   

   >> Share

   
   
7. ELLEISY M, Drager DL, Zettl H, Hakenberg OW, et al
   COVID-19 Pandemic Impact on Uro-Oncological Disease Outcomes at a German Referral Center.
   Urol Int. 2025;109:135-145.
   

   >> Share

   
   
8. SPACHMANN PJ, Witt D, Breyer J, Denzinger S, et al
   Antibiotic Prophylaxis of Transrectal Biopsy of the Prostate: A Plea for Fosfomycin.
   Urol Int. 2025;109:146-150.
   

   >> Share

   
   
9. ELLEISY M, Zettl H, Drager DL, Hakenberg OW, et al
   The Impact of Diabetes and Antidiabetics on Uro-Oncological Disease Outcomes: A Single-Center Experience.
   Urol Int. 2025;109:361-371.
   

   >> Share

   
   
10. BAHLBURG H, Bahlburg H, Rausch P, Silberg M, et al
    Stage Migration in Urological Cancers in Germany during the COVID-19 Pandemic: Fact or Fiction?
    Urol Int. 2025;109:501-507.
    

    >> Share

    
    
11. SCHMITZ-DRAGER BJ, Schmitz-Drager BJ, Bismarck E, Ebert T, et al
    Cardiovascular Safety of GnRH Agonist-Based Androgen Deprivation Therapy in a Real-World Setting: Results from a Prospective Cohort Study (LEAN).
    Urol Int. 2025;109:519-527.
    

    >> Share

    
    October 2024
12. JI G, Liu F, Chen Z, Peng J, et al
    Correlation of magnetic resonance imaging and computed tomography with biological factor expression and lymph node metastasis in aggressive prostate cancer.
    Urol Int. 2024 Oct 25:1-8. doi: 10.1159/000541953.
    

    >> Share

    
    
13. YU J, Zhou K, Wang J, Mao L, et al
    Preliminary efficacy, tolerability, and safety analysis of Darolutamide for metastatic castration?resistant prostate cancer: a single-center, open-label study.
    Urol Int. 2024 Oct 15:1-13. doi: 10.1159/000541929.
    

    >> Share

    
    
14. OPPOLZER IA, Schnabel MJ, Hammer S, Zilles H, et al
    Impact of SARS-CoV-2-Pandemic on diagnosis of prostate cancer.
    Urol Int. 2024 Oct 3:1-15. doi: 10.1159/000541753.
    

    >> Share

    
    September 2024
15. BULBUL O, Nak D, Goksel S
    Prediction of lesion-based treatment response after two cycles of Lu-177 PSMA treatment in metastatic castration-resistant prostate cancer using machine learning.
    Urol Int. 2024 Sep 30:1-12. doi: 10.1159/000541628.
    

    >> Share

    
    August 2024
16. OBERNEDER M, Henzler T, Kriegmair M, Vag T, et al
    Prediction of clinically significant prostate cancer using multi parametric MRI, biparametric MRI and clinical parameters.
    Urol Int. 2024 Aug 31. doi: 10.1159/000541152.
    

    >> Share

    
    May 2024
17. GLOGER S, Paulics L, Philippou C, Philippou S, et al
    Perioperative rates of incidental prostate cancer after aquablation and holmium laser enucleation of the prostate (HoLEP).
    Urol Int. 2024 May 27. doi: 10.1159/000539014.
    

    >> Share

    
    March 2024
18. SIMSEK A, Celen S, Duran MB, Kucuker K, et al
    THE DIAGNOSTIC ACCURACY OF A COMBINATION OF PREOPERATIVE 68-Ga PSMA PET/CT AND MULTIPARAMETRIC MRI IN LOCALIZED PROSTATE CANCER.
    Urol Int. 2024 Mar 13. doi: 10.1159/000538061.
    

    >> Share

    
    
19. HU S, Xiong X, Qiu S, Li J, et al
    Comparing efficacies of different exercises on androgen deprivation therapy adverse effects in prostate cancer patients: a network meta-analysis.
    Urol Int. 2024 Mar 2. doi: 10.1159/000538114.
    

    >> Share

    
    January 2024
20. RIEDEL A, Michael M, Grunberg J, Mehralivand S, et al
    The role of multiparametric MRI (mpMRI) in the prediction of adverse prostate cancer pathology in radical prostatectomy specimen.
    Urol Int. 2024 Jan 19. doi: 10.1159/000536256.
    

    >> Share

    
    
21. WU S, Feldman AS, Lin SX, Kim MM, et al
    Estimated Prostate Volume by Semiautomatic Segmentation of MRI Is More Accurately Correlated with Radical Prostatectomy Specimen Weight than the Volume Calculated by Ellipsoid Formula.
    Urol Int. 2024;108:35-41.
    

    >> Share

    
    
22. SIGG S, Arnold W, Grossmann NC, Baumeister P, et al
    Why Do Men Reject Adjuvant Radiotherapy following Radical Prostatectomy? A Systematic Survey.
    Urol Int. 2024;108:211-218.
    

    >> Share

    
    
23. FARZAT M, Wagenlehner FM
    How Might the Number of Lymph Nodes Removed during RARP Impact the Postoperative Outcomes?
    Urol Int. 2024;108:175-182.
    

    >> Share

    
    
24. FERRANDINO MN, Espino G, Young M, Bodden E, et al
    Initial Experience with an Absorbable Urologic Scaffold to Mitigate Early Urinary Incontinence following Radical Prostatectomy: A Report of 2 Cases.
    Urol Int. 2024;108:574-577.
    

    >> Share

    
    November 2023
25. CANKAYA S, Caylan AE, Aydin F, Ucar M, et al
    Correlation between prostate cancer positive cores and 68Ga-PSMA distribution in prostate gland.
    Urol Int. 2023 Nov 28. doi: 10.1159/000535466.
    

    >> Share

    
    
26. CUI Y, Zhao J, Sun Y
    The Value of the Prostate Health Index and Derived Indexes in the Diagnosis of Prostate Cancer with PI-RADS-3 Lesions.
    Urol Int. 2023 Nov 27:1-6. doi: 10.1159/000534597.
    

    >> Share

    
    
27. SENEL S, Koudonas A, Uzun E, Ceviz K, et al
    The Value of Prostate-Specific Antigen Density in Combination with Lesion Diameter for the Accuracy of Prostate Cancer Prediction in Prostate Imaging-Reporting and Data System 3 Prostate Lesions.
    Urol Int. 2023 Nov 20:1-6. doi: 10.1159/000534805.
    

    >> Share

    
    
28. SIKIC D, Fiebig C, Wullich B, Wolff I, et al
    Patient Benefits of Radical Prostatectomy in Certified Prostate Cancer Centers: Comparative Results from the Multicenter IMPROVE Study.
    Urol Int. 2023 Nov 6:1-10. doi: 10.1159/000534486.
    

    >> Share

    
    January 2023
29. SHEN C, Zhang DL, Cheng XL, Zhang WC, et al
    Urological Tumor: A Narrative Review of Tertiary Lymphatic Structures.
    Urol Int. 2023;107:841-847.
    

    >> Share

    
    
30. SCARCIA M, Moretto S, Zazzara M, Alba S, et al
    Robot-Assisted Extraperitoneal Radical Prostatectomy for Giant Multilocular Prostatic Cystadenoma: A Case Report and Literature Review.
    Urol Int. 2023;107.
    

    >> Share

    
    
31. STOLZENBACH LF, Fankhauser CD, Mattei A, Wurnschimmel C, et al
    Solitary Fibrous Tumor of the Prostate Treated with Frozen-Section Supported Robot-Assisted Nerve-Sparing Radical Prostatectomy.
    Urol Int. 2023;107.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share